We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Ming Bioventures

News List

Tavotek Biotherapeutics Announces Completion of Round A1 and A2 Financing with over $20 Million Dollars prnasia
March 23, 2021
Tavotek Biotherapeutics announces it has raised over $20M in Round A1 and Round A2 financing in the preceding two months. YuanBio Venture Capital led the A1 finance round followed by Oriza Holdings, Ming BioVentures, and New Alliance Capital.
WuXi Biologics to acquire CMAB Biopharma Group expresspharma
March 19, 2021
WuXi Biologics announced it has entered into a purchase agreement with CBC Group (CBC), a healthcare-dedicated investment firm, and other companies including Ming Bioventures under which WuXi Bio will acquire over 90 per cent interest of CMAB ...